Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Immunol ; 183(5): 3454-62, 2009 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-19648266

RESUMO

Prolonged Ca(2+) entry through Ca(2+) release-activated Ca(2+) (CRAC) channels is crucial in activating the Ca(2+)-sensitive transcription factor NFAT, which is responsible for directing T cell proliferation and cytokine gene expression. To establish whether targeting CRAC might counteract intestinal inflammation, we evaluated the in vitro effect of a selective CRAC inhibitor on T cell cytokine production and T-bet expression by lamina propria mononuclear cells (LPMC) and biopsy specimens from inflammatory bowel disease (IBD) patients. The inhibitory activity of the CRAC blocker was investigated through patch-clamp experiments on rat basophilic leukemia cells and fluorometric imaging plate reader intracellular Ca(2+) assays using thapsigargin-stimulated Jurkat T cells and its detailed selectivity profile defined using a range of in vitro radioligand binding and functional assays. Anti-CD3/CD28-stimulated LPMC and biopsy specimens from 51 patients with IBD were cultured with a range of CRAC inhibitor concentrations (0.01-10 microM). IFN-gamma, IL-2, IL-8, and IL-17 were analyzed by ELISA. T-bet was determined by immunoblotting. We found that the CRAC blocker concentration-dependently inhibited CRAC current in rat basophilic leukemia cells and thapsigargin-induced Ca(2+) influx in Jurkat T cells. A concentration-dependent reduction in T-bet expression and production of IFN-gamma, IL-2, IL-17, but not IL-8, was observed in IBD LPMC and biopsy specimens treated with the CRAC inhibitor. In conclusion, we provide evidence that the suppression of CRAC channel function may dampen the increased T cell response in the inflamed gut, thus suggesting a promising role for CRAC inhibitor drugs in the therapeutic management of patients with IBD.


Assuntos
Canais de Cálcio/metabolismo , Citocinas/antagonistas & inibidores , Citocinas/biossíntese , Doenças Inflamatórias Intestinais/imunologia , Doenças Inflamatórias Intestinais/patologia , Proteínas com Domínio T/antagonistas & inibidores , Subpopulações de Linfócitos T/imunologia , Subpopulações de Linfócitos T/metabolismo , Adulto , Idoso , Animais , Bloqueadores dos Canais de Cálcio/farmacologia , Linhagem Celular Tumoral , Humanos , Doenças Inflamatórias Intestinais/metabolismo , Mucosa Intestinal/imunologia , Mucosa Intestinal/metabolismo , Mucosa Intestinal/patologia , Células Jurkat , Pessoa de Meia-Idade , Técnicas de Cultura de Órgãos , Técnicas de Patch-Clamp , Ratos , Proteínas com Domínio T/fisiologia , Subpopulações de Linfócitos T/patologia , Adulto Jovem
2.
Biochem Pharmacol ; 68(8): 1655-66, 2004 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-15451409

RESUMO

Studies in heterologous systems have demonstrated that heterodimerisation of the two GABA(B) receptor subunits appears to be crucial for the trafficking and signalling of the receptor. Gene targeting of the GABA(B1) gene has demonstrated that the expression of GABA(B1) is essential for GABA(B) receptor function in the central nervous system (CNS). However, the contribution of the GABA(B2) subunit in the formation of native GABA(B) receptors is still unclear, in particular whether other proteins can substitute for this subunit. We have created a transgenic mouse in which the endogenous GABA(B2) gene has been mutated in order to express a C-terminally truncated version of the protein. As a result, the GABA(B1) subunit does not reach the cell surface and concomitantly both pre- and post-synaptic GABA(B) receptor functions are abolished. Taken together with previous gene deletion studies for the GABA(B1) subunit, this suggests that classical GABA(B) function in the brain is exclusively mediated by GABA(B1/2) heteromers.


Assuntos
Receptores de GABA-B/genética , Receptores Pré-Sinápticos/metabolismo , Sinapses/metabolismo , Animais , Encéfalo , Corpo Estriado/metabolismo , Deleção de Genes , Camundongos , Mutação , Fenótipo , Transporte Proteico , Receptores de GABA-B/imunologia , Receptores de GABA-B/metabolismo
3.
Neurosci Lett ; 367(1): 1-5, 2004 Aug 26.
Artigo em Inglês | MEDLINE | ID: mdl-15308285

RESUMO

Low-frequency stimulation (LFS) is used to induce long-term depression (LTD) and depotentiation at rodent CA3-CA1 hippocampal synapses. The relationship between the efficacy of LFS induction and postnatal age remains to be clearly defined in rat and had not been studied in mouse. The data presented here show that in acute mouse hippocampal slices LFS-induced LTD and depotentiation at CA3-CA1 synapses are: synapse specific; NMDA receptor-dependent; and metabotropic glutamate (mGlu) receptor type I/II independent. Furthermore LFS-induced LTD is highly age-dependent whilst long-term potentiation (LTP) and depotentiation are not. In slices from very young mice (P6-9) LFS induced a robust and stable LTD (-31.1 +/- 5.9%, n = 8, P < 0.01) of CA1 field excitatory post-synaptic potentials (fEPSPs), measured 55-60 min after conditioning. LFS also induced LTD in slices from mice aged P10-13 and P14-17 (-16.0 +/- 3.0%, n = 35, P < 0.001 and -17.9 +/- 5.5%, n = 12, P < 0.01, respectively). However, LTD was not expressed in slices from animals aged P18-21 ( -7.0 +/- 4.1%, n = 16, P > 0.05) or older.


Assuntos
Envelhecimento/fisiologia , Glicina/análogos & derivados , Hipocampo/citologia , Depressão Sináptica de Longo Prazo/fisiologia , Sinapses/fisiologia , Valina/análogos & derivados , Fatores Etários , Análise de Variância , Animais , Animais Recém-Nascidos , Relação Dose-Resposta a Droga , Estimulação Elétrica/métodos , Agonistas de Aminoácidos Excitatórios/farmacologia , Antagonistas de Aminoácidos Excitatórios/farmacologia , Potenciais Pós-Sinápticos Excitadores/efeitos dos fármacos , Potenciais Pós-Sinápticos Excitadores/fisiologia , Potenciais Pós-Sinápticos Excitadores/efeitos da radiação , Glicina/farmacologia , Técnicas In Vitro , Depressão Sináptica de Longo Prazo/efeitos dos fármacos , Depressão Sináptica de Longo Prazo/efeitos da radiação , Camundongos , Camundongos Endogâmicos C57BL , Sinapses/efeitos dos fármacos , Sinapses/efeitos da radiação , Valina/farmacologia
4.
Neurosci Lett ; 329(2): 217-21, 2002 Aug 30.
Artigo em Inglês | MEDLINE | ID: mdl-12165416

RESUMO

The induction of long-term potentiation (LTP) at corticostriatal synapses is dependent on the activation of postsynaptic NMDA receptors, but the mechanisms involved in the maintenance of LTP are not known. We report here that forskolin, an activator of adenylyl cyclase, induces a lasting enhancement of the corticostriatal synaptic response. This enhancement is associated with a lasting decrease in paired-pulse ratio, and is blocked by inhibitors of adenylyl cyclase and cyclic AMP-dependent protein kinase (PKA), but not by a PKA inhibitor injected into the postsynaptic cell. Tetanically-induced LTP is also associated with a decrease in paired-pulse ratio and partially occludes the subsequent action of forskolin. Our results suggest that activation of presynaptic PKA can enhance neurotransmission at corticostriatal synapses; a mechanism required for the expression of LTP at these synapses.


Assuntos
Córtex Cerebral/enzimologia , Corpo Estriado/enzimologia , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Potenciação de Longa Duração/fisiologia , Sinapses/enzimologia , Animais , Masculino , Ratos , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA